Covid-19 vaccines
Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Vaccine safety & adverse events
Safety of J&J Ad26. COV2.S vaccine: Sisonke study
SisonkeTrialReport-J&J-3b-Safety-PlosMedicine Comments: BE WARY OF CONCLUSIONS IN HEADLINES AND ABSTRACTS. Reading the abstract of this J&J Covid-19 vaccine study among South African healthcare workers leaves one with a sense of trust and confidence. The authors claim “The single-dose Ad26.CoV2.S vaccine had an acceptable safety profile supporting the continued use of this vaccine in our setting.”
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Findings on Health Issues Post-Pfizer Vaccine
Reference: Botha, Z. (2021). To whom it may concern: Herewith report on the findings of patients that had the Pfizer vaccine. [Unpublished manuscript]. Summary: The report details observations from a practitioner treating over thirty patients who experienced significant health issues following the Pfizer Covid vaccine between June and September 2021. Symptoms reported included severe headaches,
COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses
Dispelling the Myth of “A Pandemic of the Unvaccinated”
Reference: Canadian COVID Care Alliance. (2021). Dispelling the myth of “a pandemic of the unvaccinated.” Retrieved from https://canadiancovidcarealliance.org Summary: The Canadian COVID Care Alliance, comprising over 500 independent healthcare professionals, challenges the narrative that the COVID-19 pandemic is predominantly a crisis among the unvaccinated. The article argues that vaccination rates were high, yet COVID-19 cases
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Critical Review of COVID-19 Vaccines in Australia
Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review evaluates COVID-19 mRNA vaccines from an Australian perspective, focusing on their safety and efficacy. The authors discuss initial promises versus actual outcomes, citing serious side effects—including deaths—from collected case reports. They
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Comirnaty Vaccine Information
Reference: Pfizer. (2021). Comirnaty 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) tozinameran: Package leaflet. Retrieved from [insert URL here] Summary: Comirnaty is a COVID-19 mRNA vaccine designed to prevent illness caused by the SARS-CoV-2 virus, approved for adults and adolescents aged 12 and over. It functions by stimulating the immune